Hypertensive Retinopathy

Primary (Essential) Hypertension

The vast majority of hypertensive retinopathy (~90–95% of cases) is caused by primary essential hypertension — sustained elevation of blood pressure ≥140/90 mmHg (or ≥130/80 mmHg by current ACC/AHA criteria) without an identifiable secondary cause. The retinal changes reflect cumulative vascular damage proportional to the severity and duration of hypertension.

Secondary Hypertension

Secondary causes should be considered, particularly in younger patients or those with severe/resistant hypertension:

• Renal causes: Chronic kidney disease, renal artery stenosis, glomerulonephritis, polycystic kidney disease
• Endocrine causes: Primary hyperaldosteronism (Conn syndrome), phaeochromocytoma, Cushing syndrome, thyroid disease, acromegaly
• Vascular: Coarctation of the aorta
• Obstructive sleep apnoea: A common and often overlooked cause of resistant hypertension
• Medications: Oral contraceptives, NSAIDs, decongestants, stimulants, immunosuppressants (calcineurin inhibitors)

Acute / Hypertensive Crisis Contexts

• Hypertensive urgency: Severe hypertension (systolic >180 mmHg) without end-organ damage; may cause acute-onset Grade III retinal signs
• Hypertensive emergency (malignant hypertension): Severe hypertension with evidence of end-organ damage — Grade IV retinopathy with disc oedema, encephalopathy, acute kidney injury, or acute cardiac events; constitutes a medical emergency
• Pre-eclampsia / eclampsia: Pregnancy-induced hypertension; can cause acute, severe hypertensive retinopathy including serous retinal detachment; visual changes in pregnancy warrant urgent evaluation

Autoregulation of the Retinal Vasculature

The retinal vasculature normally maintains a constant blood flow across a range of perfusion pressures through autoregulation — a protective mechanism involving arteriolar vasoconstriction and vasodilation. In chronic hypertension, this system becomes overwhelmed, leading to progressive structural damage.

Biphasic Vascular Response

Hypertensive Choroidopathy

In acute severe hypertension, the choroidal vasculature (which lacks autoregulation) is particularly vulnerable. Fibrinoid necrosis of choriocapillaris lobules causes focal RPE infarcts (Elschnig spots — pigmented chorioretinal lesions) and may cause serous retinal detachments, particularly in the context of pre-eclampsia or phaeochromocytoma.

Keith-Wagener-Barker (KWB) Classification — Classic (1939)

The original KWB grading system remains widely used in clinical practice. It classifies hypertensive retinopathy on a scale of I–IV with increasing severity. Grade IV (disc oedema/papilloedema) indicates malignant hypertension — a medical emergency.

Wong-Mitchell Classification (2004) — Evidence-Based

Wong and Mitchell proposed a simplified, evidence-based classification based on population studies linking retinal signs to cardiovascular outcomes. It divides hypertensive retinopathy into three categories with greater clinical utility and better inter-observer agreement.

Scheie Classification (Historical)

Primary Risk Factors

• Uncontrolled or poorly controlled hypertension: The primary driver; both severity and duration of hypertension correlate directly with retinopathy severity
• Duration of hypertension: Chronic exposure accumulates arteriosclerotic changes (Grades I–II) that are irreversible
• Level of blood pressure: Systolic hypertension is more strongly associated with retinopathy than diastolic; systolic BP >160 mmHg markedly increases risk
• Blood pressure variability: Wide short-term fluctuations in BP may be as harmful as sustained elevation

Systemic Co-morbidities

• Diabetes mellitus: Markedly amplifies retinal vascular damage — combined hypertensive and diabetic retinopathy has additive or synergistic effects; accelerates hard exudate formation and macular oedema
• Hyperlipidaemia/dyslipidaemia: Promotes hard exudate formation and arteriosclerosis; high LDL is associated with more pronounced exudate deposition in the macula
• Chronic kidney disease (CKD): Renal disease worsens hypertension and independently contributes to arteriosclerotic retinal changes
• Obesity: Associated with hypertension, metabolic syndrome, and their retinal sequelae
• Atherosclerotic cardiovascular disease: Shared pathophysiology; retinal arteriosclerosis reflects systemic vessel disease

Lifestyle and Demographic Factors

• Age: Older age is independently associated with more severe arteriolar changes due to accumulative arteriosclerosis; must distinguish age-related arteriolar changes from hypertensive changes
• Smoking: Directly damages vascular endothelium; potentiates hypertensive vascular injury; increases risk of retinal vascular occlusion
• Sedentary lifestyle and high salt intake: Modifiable risk factors for hypertension itself
• Ethnicity: Higher prevalence of hypertensive retinopathy in Black and South/Southeast Asian populations, reflecting higher background hypertension prevalence and severity
• Pregnancy: Pre-eclampsia and eclampsia can precipitate acute, severe hypertensive retinopathy; a specific high-risk context

Arteriolar Signs (Chronic Changes)

• Generalised arteriolar narrowing: The most common early sign. Assessed by the arteriole-to-venule (A/V) ratio — normal is approximately 2:3 (0.67); a ratio of <0.5 indicates significant narrowing. Diffuse narrowing reflects arteriolar vasoconstriction and/or fibrosis
• Focal arteriolar narrowing: Localised segments of arteriolar constriction — often described as "sausage-link" or "beading" appearance; more specific than generalised narrowing for hypertensive disease
• Copper wiring: Increased opacity of the arteriolar wall from intimal thickening and hyaline degeneration — the arteriole appears to have a copper-coloured reflex rather than the normal bright red blood column
• Silver wiring: More advanced arteriolar opacity — the blood column is completely obscured by the thickened, fibrotic wall, giving a silver/white wire appearance; indicates severe arteriosclerosis
• Arteriovenous (AV) nicking: Compression of the underlying venule at arteriole crossing points — the venule appears deflected, tapered, or obscured on either side of the crossing (Salus sign: deflection; Gunn sign: tapering); an important and reliable sign of arteriosclerosis

Exudative Signs (Acute / Severe Changes)

• Flame-shaped haemorrhages: Intraretinal haemorrhages in the nerve fibre layer; follow the orientation of nerve fibres, producing a linear/splinter-like shape; most numerous in the posterior pole near disc
• Blot haemorrhages: Deeper intraretinal haemorrhages in the inner nuclear or outer plexiform layer; round/blot shape; may indicate associated diabetes or vascular occlusion
• Cotton wool spots (CWS): White, fluffy, superficial retinal lesions; caused by focal ischaemic infarction of the nerve fibre layer; axonal cytoplasm accumulates at the border of the infarct; resolve over 6–12 weeks leaving no visible trace
• Hard exudates: Cream-yellow deposits in the outer plexiform layer; composed of leaked lipoproteins and lipid-laden macrophages; arranged in clusters or lines; in the macula may form a partial or complete star pattern (macular star) radiating from the fovea along Henle fibres
• Macular star: A pathognomonic arrangement of hard exudates in a stellate pattern centred on the fovea; forms as exudates leak from peripapillary or posterior pole arterioles; not specific to hypertension (also seen in neuroretinitis) but highly characteristic

Optic Disc Signs

• Disc oedema (hypertensive papillopathy): Bilateral disc swelling from ischaemia of the optic nerve head and axoplasmic stasis; blurred disc margins, disc hyperaemia, splinter haemorrhages at disc margin; the hallmark of Grade IV / malignant hypertension
• Peripapillary haemorrhages: Flame-shaped haemorrhages adjacent to the optic disc margin; common in Grade III–IV disease

Choroidal Signs

• Elschnig spots: Small black dots surrounded by a yellow halo — areas of RPE hyperplasia around focal choriocapillaris infarcts; seen in acute severe hypertension
• Siegrist streaks: Linear hyperpigmented streaks along choroidal vessels — rare; indicate fibrinoid necrosis of choroidal vessels
• Serous retinal detachment: From choroidal ischaemia with fluid accumulation under the neurosensory retina; more common in pre-eclampsia and phaeochromocytoma-related hypertension

Early / Mild Disease (Grades I–II)

• Typically asymptomatic: Generalised arteriolar narrowing and AV nicking cause no subjective visual symptoms
• Incidental finding on routine fundoscopy; the patient may have no knowledge of hypertension

Moderate Disease (Grade III)

• Blurred vision: From macular oedema, hard exudates in the fovea, or macular star formation affecting central vision
• Scotoma (visual field defect): Corresponding to areas of haemorrhage, cotton wool spots, or ischaemia
• Metamorphopsia: Distorted central vision from macular exudates or subretinal fluid
• Reduced colour discrimination: From macular involvement

Severe / Malignant Disease (Grade IV)

• Sudden or rapidly progressive visual loss: From disc oedema, macular ischaemia, or associated retinal vascular occlusion
• Severe headache: A key symptom of hypertensive encephalopathy — occipital or diffuse; may accompany disc oedema
• Nausea and vomiting: In hypertensive crisis with raised intracranial pressure
• Transient visual obscurations: Brief episodes of visual greying or blackout, particularly on postural change
• Diplopia: Rarely, from hypertensive cranial nerve palsies or stroke
• Visual field loss: From retinal or optic nerve ischaemia; may be altitudinal, central, or quadrantic depending on the territory affected

Vascular Occlusion Symptoms

• Sudden painless visual loss: In retinal artery or vein occlusion — a complication of hypertensive arteriosclerosis; may be sectoral (branch) or total (central)
• Amaurosis fugax: Transient monocular visual loss from embolic arteriolar occlusion — a TIA equivalent requiring urgent investigation

Retinal Vascular Occlusions

• Branch retinal vein occlusion (BRVO): AV nicking from arteriosclerosis compresses the vein at the crossing, predisposing to thrombosis; causes sectoral intraretinal haemorrhages, macular oedema, and visual field loss; hypertension is the most important risk factor
• Central retinal vein occlusion (CRVO): Thrombosis at the lamina cribrosa; causes disc oedema, diffuse haemorrhages in all quadrants, dilated tortuous veins, and macular oedema; risk of neovascular glaucoma
• Branch retinal artery occlusion (BRAO): Embolic or thrombotic occlusion of a branch arteriole; causes sectoral retinal whitening and corresponding visual field loss; associated with carotid and cardiac disease
• Central retinal artery occlusion (CRAO): Catastrophic; causes sudden, painless, near-total monocular vision loss; retinal oedema with cherry red spot at fovea; requires emergency assessment for embolic source and stroke risk

Macular Complications

• Macular oedema: From capillary leakage in severe hypertension; causes blurred central vision and metamorphopsia; may reduce visual acuity significantly
• Macular star: Persistent hard exudate deposition in the foveal region; can cause prolonged central visual impairment even after BP normalisation; exudates may take months to resolve
• Macular ischaemia: From perifoveal capillary dropout; causes permanent central scotoma; may complicate both hypertension and retinal vascular occlusion
• Choroidal neovascular membrane (CNV): Rarely, chronic hypertensive choroidopathy with RPE damage may predispose to CNV formation

Optic Nerve Complications

• Hypertensive optic neuropathy (disc oedema): Bilateral; a medical emergency indicating malignant hypertension; may progress to optic atrophy if untreated
• Non-arteritic ischaemic optic neuropathy (NAION): Hypertension is a major risk factor; sudden altitudinal visual field loss; associated with small cup-to-disc ratio
• Optic atrophy: End-stage consequence of untreated hypertensive optic neuropathy or severe ischaemia

Other Ocular Complications

• Vitreous haemorrhage: From rupture of neovascular vessels secondary to retinal ischaemia (typically after CRVO with neovascularisation)
• Serous retinal detachment: From hypertensive choroidopathy; more common in acute severe hypertension (pre-eclampsia, phaeochromocytoma)
• Neovascular glaucoma: Secondary to CRVO with anterior segment neovascularisation; very elevated IOP; difficult to manage

Retinal Signs as Systemic Disease Markers

The retinal vasculature is the only site in the body where small vessels can be directly observed non-invasively. Population-based studies have established that hypertensive retinal signs are independent predictors of systemic cardiovascular and cerebrovascular events, beyond blood pressure levels alone.

Associated Systemic Conditions

• Stroke (ischaemic and haemorrhagic): Hypertension is the single most important modifiable risk factor for stroke; retinal arteriolar narrowing and AV nicking independently predict stroke risk beyond BP alone
• Coronary heart disease (MI, angina): Shared vascular pathology; moderate retinopathy signs significantly increase risk of fatal and non-fatal MI
• Heart failure: Hypertensive cardiomyopathy (left ventricular hypertrophy → diastolic and systolic dysfunction); disc oedema in malignant HTN is often accompanied by acute pulmonary oedema
• Chronic kidney disease (CKD): Bidirectional relationship — hypertension causes renal arteriosclerosis and CKD; CKD worsens hypertension control; GFR decline correlates with retinopathy severity
• Carotid artery disease: Systemic arteriosclerosis reflected in retinal vessels; emboli from carotid plaques cause BRAO and amaurosis fugax
• Aortic dissection: A catastrophic complication of hypertensive crisis; may present with sudden onset visual symptoms from retinal ischaemia
• Pre-eclampsia / eclampsia: Hypertensive retinopathy in pregnancy, including serous retinal detachment and disc oedema, reflects the severity of systemic vascular endothelial dysfunction; indicates risk to mother and foetus
• Hypertensive encephalopathy: In malignant hypertension, cerebral oedema presents with headache, confusion, and seizures alongside Grade IV retinopathy — a neurological emergency

Ophthalmoscopy / Fundoscopy

• Direct ophthalmoscopy: Accessible first-line tool; identifies disc oedema and gross vascular changes; limited field of view
• Binocular indirect ophthalmoscopy: Wider field; better for peripheral assessment and scleral indentation; requires dilation
• Slit-lamp biomicroscopy (90D or 78D lens): Best for detailed posterior pole assessment including macular star, hard exudate distribution, and disc oedema margins
• Mydriatic fundus photography: Documents and monitors retinal changes over time; allows grading by comparison with standardised reference images; important for referral communication
• Non-mydriatic retinal camera: Increasingly used in primary care and optometry for opportunistic screening

Blood Pressure Measurement

• Mandatory in all patients with hypertensive retinal signs — particularly when hypertension is newly detected
• Use calibrated sphygmomanometer; two readings at least 1 minute apart; both arms initially
• In-clinic BP ≥180/120 mmHg with retinal signs (Grade III–IV) constitutes hypertensive urgency/emergency requiring same-day medical care
• Consider 24-hour ambulatory BP monitoring (ABPM) for white-coat effect, nocturnal dipping patterns, and BP variability assessment

Optical Coherence Tomography (OCT)

• Macular OCT: Quantifies macular oedema; identifies subretinal fluid; delineates hard exudate distribution in the outer plexiform layer; detects and monitors macular changes not visible on slit-lamp biomicroscopy
• Optic disc OCT / retinal nerve fibre layer (RNFL) analysis: Measures disc oedema; quantifies RNFL thickness; baseline for monitoring resolution with BP treatment
• OCT angiography (OCTA): Non-invasive visualisation of retinal and choroidal vasculature; detects capillary dropout zones; useful for assessing macular ischaemia in the absence of fluorescein; increasingly available in clinical practice

Fluorescein Angiography (FFA)

• Not routinely required for diagnosis of hypertensive retinopathy
• Useful in equivocal cases to confirm arteriolar non-perfusion, leakage from disc oedema, macular ischaemia, and document vascular occlusion patterns
• May help differentiate hypertensive from diabetic retinopathy when clinical features overlap

Systemic Investigations (Initiated by GP / Physician)

• Urine analysis: Protein (nephropathy), haematuria (renal disease)
• Renal function (eGFR, creatinine): Hypertensive nephropathy assessment
• Fasting glucose / HbA1c: Co-existing diabetes
• Lipid profile: Dyslipidaemia management
• ECG and echocardiogram: Left ventricular hypertrophy, cardiac failure
• MRI/CT brain: In Grade IV with encephalopathy or new neurological signs
• Secondary hypertension workup: Renal ultrasound, endocrine panels (aldosterone, cortisol, metanephrines) in appropriate clinical context

Referral Urgency by Grade

Antihypertensive Treatment (Physician-Led)

The cornerstone of hypertensive retinopathy management is blood pressure control. Retinal changes in Grades I–II (vascular) may stabilise but not fully reverse with BP control; exudative signs (Grade III) can show significant resolution over weeks to months.

• Target BP: <140/90 mmHg for most patients; <130/80 mmHg for those with diabetes, CKD, or established cardiovascular disease (NICE/MOH guidelines)
• First-line agents: ACE inhibitors / ARBs, calcium channel blockers, thiazide diuretics — selected based on co-morbidities
• Malignant hypertension: Controlled, gradual BP reduction (not rapid) in hospital; target 20–25% reduction in mean arterial pressure within first hour; oral labetalol, amlodipine, or IV labetalol; avoid over-rapid correction (risk of ischaemic stroke or renal hypoperfusion)
• Lifestyle modification (adjunctive): Dietary salt restriction (<6g/day), regular aerobic exercise, weight loss, alcohol moderation, smoking cessation

Management of Retinal Complications

• Macular oedema / hard exudates: Resolution follows BP normalisation; intravitreal anti-VEGF or laser may be considered by a retinal specialist if oedema persists despite optimal BP control
• BRVO / CRVO: Managed as vascular occlusion; intravitreal anti-VEGF (ranibizumab, aflibercept) or dexamethasone implant for macular oedema; treat underlying hypertension
• BRAO / CRAO: Urgent ophthalmology and medical assessment for embolic source; systemic investigation for carotid disease, cardiac emboli; antiplatelet therapy after ischaemic event
• Neovascular glaucoma (after CRVO): Panretinal photocoagulation, intravitreal anti-VEGF, and glaucoma medical/surgical therapy
• Disc oedema: Resolves with BP normalisation; persistent optic atrophy managed with low vision rehabilitation if significant field loss remains

Monitoring in Optometry Practice

• Fundus photography at each monitoring visit for serial comparison
• OCT macula when macular oedema or exudates are present
• Visual acuity and visual fields as baseline and at follow-up
• BP measurement at each visit for patients with known hypertension
• Reinforce medication adherence and lifestyle modifications at each visit
• Document grading using a standardised system (KWB or Wong-Mitchell) in all communications

Visual Prognosis

Systemic Prognosis

• Moderate retinopathy signs (haemorrhages, CWS, exudates) independently predict 2–3× increased risk of stroke, MI, and cardiovascular death, even after adjustment for BP level
• Effective antihypertensive treatment reduces cardiovascular event risk substantially — but does not fully reverse arteriosclerotic retinal changes (Grades I–II)
• BP control to targets (<140/90 or <130/80 mmHg) is the single most effective intervention for improving both visual and systemic prognosis
• Untreated malignant hypertension carries a 1-year mortality of ~80–90% (historical data); with modern treatment, 5-year survival exceeds 75%